Azacitidine Injection, Powder, Lyophilized, For Solution
Product Images NDC 68001-620

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Azacitidine (NDC 68001-620). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bluepoint Laboratories., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Carton 100 mg Per Vial (Carton)

Azacitidine For Injection 100 mg/vial lyophilized powder for intravenous and subcutaneous use. The carton shows the labeler as BluePoint Laboratories with manufacturing by Dr. Reddy's Laboratories Limited in India. The product is a cytotoxic agent that must be diluted prior to use and comes as a single-dose vial. The label includes dosage storage instructions and warnings to keep out of reach of children.*

FDA Label Image

Vial Label 100 mg Per Vial (Vial)

Label for Azacitidine For Injection 100 mg/vial, a lyophilized powder for solution injection intended for subcutaneous and intravenous use. The label states it is a cytotoxic agent, requires dilution before use, and is supplied as a single-dose vial. Manufactured by Dr. Reddy's Laboratories Limited for BluePoint Laboratories, with storage instructions and a barcode visible.*

FDA Label Image

Graph (Graph)

A Kaplan-Meier survival curve showing proportion surviving over time (months) from randomization, comparing two groups labeled AZA and CCR. The plot includes number at risk below the x-axis and statistical values such as log-rank p-value, hazard ratio (HR), and death counts for each group.*

FDA Label Image

Structure (Structure)

Chemical structure of Azacitidine showing its molecular arrangement with nitrogen, oxygen, and hydroxyl groups attached to a pyrimidine ring and ribose sugar moiety. The structure illustrates the key atoms and bonds characteristic of the active ingredient Azacitidine.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.